BRUSSELSEuropean Union regulators handed down fines totaling  million  million to French pharmaceutical company Laboratoires Servier SA and five generic drug producers on Wednesday for colluding to delay a cheaper version of a bloodpressure medicine The decision is the third and by far the largest set of fines imposed by EU antitrust authorities for socalled payfordelay deals in the pharmaceutical industry in which drug makers are accused of paying generic rivals to delay the introduction of cheaper versions
  